Pharmacokinetic and adaptation factors involved in testicular toxicity

Federation Proceedings
|January 1, 1980
PubMed

Insights

Male germ cells possess a protective barrier and detoxication mechanisms against toxicants. DNA repair occurs in early germ cells but not mature sperm, influencing reproductive toxicity assessments.

Area of Science:

  • Toxicology
  • Reproductive Biology
  • Molecular Toxicology

Background:

  • Male gonads have unique pharmacokinetic barriers and metabolic processes influencing toxicant exposure.
  • Germ cells are protected by the blood-testis barrier, similar to the blood-brain barrier.
  • Toxication and detoxication pathways exist within both seminiferous tubules and interstitial compartments.

Purpose of the Study:

  • To investigate factors affecting toxicant effects in male gonads.
  • To understand the role of pharmacokinetics, DNA damage, and repair in male reproductive toxicity.
  • To enhance the reliability of extrapolating animal data to human risk assessment.

Main Methods:

  • Pharmacokinetic analysis of toxicant absorption, distribution, activation, and detoxication.
  • Assessment of covalent binding to macromolecules and DNA damage.
  • Investigation of DNA repair mechanisms in different male germ cell types.

Main Results:

  • The blood-testis barrier significantly limits toxicant penetration into male germ cells.
  • Detoxication processes are more prevalent in seminiferous tubules, favoring germ cell protection.
  • Unscheduled DNA repair is present in spermatogonia and spermatocytes but absent in spermatids and sperm.
  • DNA repair capacity is dose-dependent and saturable.

Conclusions:

  • Understanding male gonadal toxicokinetics and DNA repair is crucial for assessing reproductive and genetic toxicity.
  • The identified mechanisms aid in comparing species sensitivity to toxicants.
  • This knowledge improves the accuracy of extrapolating animal toxicity data to humans for risk assessment.

Related Concept Videos

Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...